Search hospitals > Georgia > Augusta
MBCCOP - Medical College of Georgia Cancer Center
Claim this profileAugusta, Georgia 30912
Global Leader in Solid Tumors
Global Leader in Breast Cancer
Conducts research for Leukemia
Conducts research for Cancer
Conducts research for Acute Myelogenous Leukemia
103 reported clinical trials
9 medical researchers
Summary
MBCCOP - Medical College of Georgia Cancer Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Solid Tumors, Breast Cancer, Leukemia, Cancer, Acute Myelogenous Leukemia and other specialties. MBCCOP - Medical College of Georgia Cancer Center is involved with conducting 103 clinical trials across 237 conditions. There are 9 research doctors associated with this hospital, such as Sharad Ghamande, Jorge Cortes, MD, Vamsi Kota, MD, and Locke J. Bryan.Area of expertise
1Solid Tumors
Global LeaderStage IV
CCNE1 positive
CLDN6 positive
2Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
Top PIs
Sharad GhamandeAugusta University Medical Center2 years of reported clinical research
Expert in Ovarian Cancer
Expert in Breast Cancer
72 reported clinical trials
150 drugs studied
Jorge Cortes, MDGeorgia Cancer Center at Augusta University6 years of reported clinical research
Studies Chronic Myeloid Leukemia
Studies Leukemia
14 reported clinical trials
19 drugs studied
Vamsi Kota, MDAugusta University Medical Center1 year of reported clinical research
Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
11 reported clinical trials
43 drugs studied
Locke J. BryanAugusta University Medical Center6 years of reported clinical research
Studies Lymphoma
Studies Follicular Lymphoma
9 reported clinical trials
20 drugs studied
Clinical Trials running at MBCCOP - Medical College of Georgia Cancer Center
Cancer
Acute Myeloid Leukemia
Non-Hodgkin's Lymphoma
Leukemia
Cervical Cancer
Ovarian Cancer
Multiple Myeloma
Solid Tumors
Chronic Myeloid Leukemia
Acute Myelogenous Leukemia
Lurbinectedin + Doxorubicin
for Leiomyosarcoma
The primary objective of this phase III study is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma (LMS) prolongs the progression-free survival (PFS) by Independent Review Committee (IRC) when compared to doxorubicin administered as a single agent.
Recruiting2 awards Phase 318 criteria
Cell Therapy
for Non-Hodgkin's Lymphoma
This trial tests a new treatment where a patient's own immune cells are enhanced to fight difficult-to-treat lymphoma. It targets patients whose cancer hasn't responded to at least two other treatments. The modified cells aim to better recognize and attack the cancer. This new method improves the ability of the patient's immune cells to find and destroy cancer cells.
Recruiting1 award Phase 219 criteria
INX-315
for Advanced Cancer
This trial is testing INX-315, a new pill that blocks a protein helping cancer cells grow. It targets patients with advanced cancers who did not respond to other treatments. The drug aims to slow or stop cancer growth by blocking a key protein.
Recruiting1 award Phase 1 & 27 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at MBCCOP - Medical College of Georgia Cancer Center?
MBCCOP - Medical College of Georgia Cancer Center is a medical facility located in Augusta, Georgia. This center is recognized for care of Solid Tumors, Breast Cancer, Leukemia, Cancer, Acute Myelogenous Leukemia and other specialties. MBCCOP - Medical College of Georgia Cancer Center is involved with conducting 103 clinical trials across 237 conditions. There are 9 research doctors associated with this hospital, such as Sharad Ghamande, Jorge Cortes, MD, Vamsi Kota, MD, and Locke J. Bryan.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.